[Conservative hormonal therapy for endometrial cancer].
Susumu
Nobuyuki
N
Department of Obstetrics & Gynecology, Keio University School of Medicine.
Aoki
Daisuke
D
Tamada
Yutaka
Y
Banno
Koji
K
Suzuki
Atsushi
A
Suzuki
Nao
N
Nozawa
Shiro
S
D000077713:17 alpha-Hydroxyprogesterone Caproate; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D016889:Endometrial Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage* / Q000009:adverse effects; D019290:Megestrol Acetate; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009367:Neoplasm Staging; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D006908:Hydroxyprogesterones; D000077713:17 alpha-Hydroxyprogesterone Caproate; D017258:Medroxyprogesterone Acetate; D019290:Megestrol Acetate